followed
2008
involved
clinically
increasingly
frequently
knowledge
1470
confidence
cros
apr
employment
used
paperid
issue
only
release
require
method
patel
respected
hasanuddin
among
familydoctor
harbig
convey
practice
bugi
here
prove
23097415
disease
implemented
capture
particular
than
abuse
270
meant
experienced
recommendation
1473
IRJP
faculty
major
asian
offer
visitor
patients6
suggested
answered
cent
ijphrd
aware
inhibition
nih
addition
gov
differ
because
should
noticed
azizah
promise
female
COX
dec
1472
gastrointestinal
quality
effective
healthcare
well
attention
demographic
frequent8
sina
information
met
feeling
non
drug
1037
getov
especially
city
much
nonselective
pharmacology
term
use11
table
CS
olesen
prostaglandin
finnish
renal
martikainen
professional
315
VK
many
determined
prescription
aspx
pointed
likely
2ibnu
make
elderly
agreement
nonprescription
pract
development
consumer
symptom
author
stomach
called
biol
earlier
may
inter
DOI
constraint
help
tract
subin
nephrotoxic
healing
EM
prefer
use1
percentage
economical
ignorance
25674444
2019
funding
sci
gender
USE
see
samplingmethod
interstitial
correctly
demand
reported
obtained
nlm
reduce
khaja
growing
answering
alternative
interview
sampling
society
need
scholarsresearchlibrary
paper_info
companie
based
shop
must
doctor
coressponding
relieve
saleem
facilitie
potential
distribution
rest
change
clinical
jaiswal
distributing
pharmacist
conducted
run
questioned
int
failure
north
2016
device
v11
collection
flow
significantly
catecholamine
active
certain
keep
minority
work
responsibility
relevant
safe
szu
provide
international
PREFERENCES
KM
indonesia
even
dose
scholar
strongest
illnesse
emerging
129612
sympathy
spreading
cejph
education
generic
prevalence
service
re
developing
toward
angiotensin
feb
rabiy
papillary
probably
happen
incidentally
mean
2014
safety
PGE2
II
sicknes
khalid
such
predictive
awarenes
congestive
including
more
com
product4
care10
consultation
798
over
shown
any
taking
springerplu
conduit
second
available
495
largest
chronic
number
committee
use
salt
habit
risk
expert
appropriately
rationalize
self
scheme
SD
sontakke
rate
fiscal
bleeding
NSAID
adverse
responsible
viewed
private
cjp
housewife
karger
obtain
200
reliable
respondent
period
show
majority
powerful
comorbid
misbelieve
generation
2010
muslim
pharmaceutical
conclusion
spent
inflammatory
label
111
today
great
SA
without
informed
lettre
ignored
JR
sense
overlooking
primary
improved
lack
research
inhibit
result
145
particularly
control
statu
health
necrosi
hendra
them
ANALGESICS
143
range
rohit
meal
preference
medicine
ailment
accidentally
pimpalkhute
role
tribal
member
keyword
amongst
abstract
therapeutic
pharmacia
sectional
2013
reading
seen
frequent
patient
studie
pharmacie
educating
study
regarding
low
factor
clearance
still
interest
library
RK
pain
occurrence
anti
STUDY
innovareacademic
world
institute
hyperkalemia
conflict
treating
concluded
weather
important
there
procedure
MZ
positive
pubmed
cheaper
dilip
about
nur
custom
GI
survey
aforementioned
ajpcr
mentioned
instruction
SAFETY
paracetamol
improving
publ
advising
previou
introduction
COUNTER
technique
high
variou
saving
questionnaire
erratic
level
population
encounter
OF
journal
chance
according
vol
OTC
very
accordance
wa
often
attitude
pandey
sihvo
rule
prevent
ha
internet
type
also
word
herman1
proper
correct
ulcer
side
system
data
inaccessibility
sample
11049013
people
public
37506
popular
store
frequency
each
due
lefterofa
mail
supervision
year
agu
national
cause
pdf
estonia
throughout
ethic
problem
giving
one
fulltext
not
funded
helping
highlighted
mucosa
quantitative
equivalent
how
benefit
through
material
related
multiple
studied
common
approved
decision
analysi
described
pharmacol
statistical
med
taken
ON
had
determine
community
suitable
vol3issue1
providing
student
brochure
read
filled
poverty
vasodilator
practiced
line
vasocontrictor
seriou
approach
azizah1
extensive
since
reference
215
know
save
medication
mohan
1pharmacology
their
record
SR
although
urge
future
law
medicinal
gastric
certainly
diabetic
persist
OA
polypharmacy
showed
laboratory
eur
source
improve
confirmed
analgesic
PGI2
first
headache
ethical
therei
simplest
who
order
packaging
out
respond
adult
most
expressed
2011
der
accompanied
barat
volmer
waiting
treat
availability
thank
educate
group
different
modified
analyzed
therefore
absence
get
www
never
part
influenced
evaluation
illnes
occur
ncbi
when
clin
2971
sequeira
statutory
permission
handu
difficulty
exposure
give
accurate
age
lefterova
obtaining
management
lead
urban
visit
simultaneou
essential
heart
condition
provider
january
relieved
known
product
medication7
MONITORING
nephriti
other
dosage
bear
resource
2006
ask
objective
play
MEDICATIONS
damsgaard
far
form
characteristic
CONSUMERS
http
considerable
trend
halima
concern
partie
mostly
countrie
fever
vidya
it
html
rizqi
1471
school
using
CD
hemminki
while
advice
bajait
university
cirrhosi
org
will
purchased
excretion
further
produce
take
familie
practicing
gupta
incidental
pharm
duty
indian
illnesses3
variability
pharmacoepidemiol
economic
interaction
edu
individual
organization
water
significant
awad
umi
treatment
cytoprotective
cited
retention
importance
third
discussion
advertisement
verma
sep
possible
cannot
investigator
widely
influenza
blood
sodium
associated
decreased
trust
biological
comprehensive
2000
biomedscidirect
asking
action
article
makassar
klaukka
steroid
abahussain
general
right
validated
reason
between
2012
princ
henry
devika
after
chem
india
distributed
comparative
experience
effect
time
ASPECTS
greater
before
128
upper
but
all
synthesi
pharmacies2
gavronski
OVER
care
194050
physician
medical
male
upon
manufacturer
long
assessment
WHO
HABITS
saf
hospital
counter
geethu
kuwait
LP2S
family
labeled
2004
single
patients5
designed
they
anyone
did
pharmacy
2020
daily
appropriate
considered
universita